Dignitana to participate in Stockholm Corporate Finance 12[th] Life Science Seminar on March 12

Files for download
Dignitana Release - wkr0006.pdf

Dignitana AB will attend Stockholm Corporate Finance Life Science Seminar at Berns in Stockholm on March 12, 2020, and at 09.30 CEO William Cronin will present the latest developments and the future for the company.

Stockholm Corporate Finance organizes the capital market day for the twelfth year in a row which gives investors, analysts and media the opportunity to meet companies in the Life Science & Health Care industry. The presentations are webcast and can be viewed directly by clicking on the link. https://financialhearings.com/event/12253


For More Information Contact

Investor Relations +1 469 518 5031 investorrelations@dignitana.com


About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.comEric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 certifiedadviser@penser.se www.penser.se